ASBP
Price
$0.51
Change
-$0.03 (-5.56%)
Updated
Sep 5 closing price
Capitalization
N/A
ORIC
Price
$10.88
Change
+$0.11 (+1.02%)
Updated
Sep 5 closing price
Capitalization
1.06B
64 days until earnings call
Interact to see
Advertisement

ASBP vs ORIC

Header iconASBP vs ORIC Comparison
Open Charts ASBP vs ORICBanner chart's image
Aspire Biopharma Holdings
Price$0.51
Change-$0.03 (-5.56%)
Volume$751.49K
CapitalizationN/A
Oric Pharmaceuticals
Price$10.88
Change+$0.11 (+1.02%)
Volume$1.05M
Capitalization1.06B
ASBP vs ORIC Comparison Chart in %
Loading...
ASBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASBP vs. ORIC commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASBP is a Buy and ORIC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (ASBP: $0.51 vs. ORIC: $10.88)
Brand notoriety: ASBP and ORIC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASBP: 5% vs. ORIC: 108%
Market capitalization -- ASBP: $0 vs. ORIC: $1.06B
ASBP [@Biotechnology] is valued at $0. ORIC’s [@Biotechnology] market capitalization is $1.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASBP’s FA Score shows that 1 FA rating(s) are green whileORIC’s FA Score has 1 green FA rating(s).

  • ASBP’s FA Score: 1 green, 4 red.
  • ORIC’s FA Score: 1 green, 4 red.
According to our system of comparison, both ASBP and ORIC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASBP’s TA Score shows that 3 TA indicator(s) are bullish while ORIC’s TA Score has 5 bullish TA indicator(s).

  • ASBP’s TA Score: 3 bullish, 5 bearish.
  • ORIC’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ORIC is a better buy in the short-term than ASBP.

Price Growth

ASBP (@Biotechnology) experienced а -11.02% price change this week, while ORIC (@Biotechnology) price change was +6.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ORIC is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORIC YTD gains are higher at: 34.820 vs. ASBP (-95.549).
ASBPORICASBP / ORIC
CapitalizationN/A1.06B-
EBITDAN/A-148.48M-
Gain YTD-95.54934.820-274%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A283M-
Total DebtN/A3.27M-
TECHNICAL ANALYSIS
Technical Analysis
ASBPORIC
RSI
ODDS (%)
Bearish Trend 3 days ago
21%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
46%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
26%
Bullish Trend 3 days ago
81%
MACD
ODDS (%)
Bearish Trend 3 days ago
22%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
36%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
38%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 5 days ago
42%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 19 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
24%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ASBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA350.8412.31
+3.64%
Tesla
GME22.610.24
+1.07%
GameStop Corp
AAPL239.69-0.09
-0.04%
Apple
SPY647.24-1.88
-0.29%
SPDR® S&P 500® ETF
BTC.X110224.695000-426.289060
-0.39%
Bitcoin cryptocurrency

ASBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASBP has been loosely correlated with SPRO. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ASBP jumps, then SPRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASBP
1D Price
Change %
ASBP100%
-6.04%
SPRO - ASBP
62%
Loosely correlated
+0.47%
ALZN - ASBP
43%
Loosely correlated
+2.20%
ORIC - ASBP
29%
Poorly correlated
+1.02%
BRNS - ASBP
26%
Poorly correlated
-6.77%
CGEM - ASBP
23%
Poorly correlated
+1.16%
More

ORIC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with ROIV. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
+1.02%
ROIV - ORIC
47%
Loosely correlated
+2.78%
KYMR - ORIC
46%
Loosely correlated
+3.10%
ERAS - ORIC
45%
Loosely correlated
+8.78%
ETNB - ORIC
45%
Loosely correlated
+3.02%
NRIX - ORIC
43%
Loosely correlated
+8.66%
More